Kardium

Published

Kevin Chaplin, CEO of Kardium, joins Nasdaq's Kristina Ayanian to share more about the atrial fibrillation market and how their business has a unique approach to solving an issue millions of people face.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now